Filing Details
- Accession Number:
- 0001127602-18-029360
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-03 16:07:23
- Reporting Period:
- 2018-10-01
- Accepted Time:
- 2018-10-03 16:07:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
64803 | Cvs Health Corp | CVS | Retail-Drug Stores And Proprietary Stores (5912) | 050494040 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1479663 | Lisa Bisaccia | One Cvs Drive Woonsocket RI 02895 | Evp And Chief Hr Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-10-01 | 7,764 | $45.07 | 28,850 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-10-01 | 7,764 | $80.00 | 21,086 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2018-10-01 | 13,770 | $54.53 | 34,856 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-10-01 | 13,770 | $80.00 | 21,086 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Disposition | 2018-10-01 | 7,764 | $0.00 | 7,764 | $45.07 |
Common Stock | Stock Option | Disposition | 2018-10-01 | 13,770 | $0.00 | 13,770 | $54.53 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2013-04-02 | 2019-04-02 | No | 4 | M | Direct |
0 | 2014-04-01 | 2020-04-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock (Restricted) | 17,430 | Direct | |
Esop Common Stock | 593 | Indirect | Direct |
Stock Unit | 30,784 | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Phantom Stock Credits | $1.00 | 468 | 468 | Direct | ||
Common Stock | Stock Option | $74.29 | 2015-04-01 | 2021-04-01 | 25,177 | 25,177 | Direct |
Common Stock | Stock Option | $102.26 | 2016-04-01 | 2022-04-01 | 34,241 | 34,241 | Direct |
Common Stock | Stock Option | $104.82 | 2017-04-01 | 2023-04-01 | 39,433 | 39,433 | Direct |
Common Stock | Stock Option | $78.05 | 2018-04-03 | 2024-04-03 | 55,098 | 55,098 | Direct |
Common Stock | Stock Option | $62.21 | 2019-04-01 | 2025-04-01 | 64,222 | 64,222 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
468 | 468 | Direct | |
2021-04-01 | 25,177 | 25,177 | Direct |
2022-04-01 | 34,241 | 34,241 | Direct |
2023-04-01 | 39,433 | 39,433 | Direct |
2024-04-03 | 55,098 | 55,098 | Direct |
2025-04-01 | 64,222 | 64,222 | Direct |
Footnotes
- All transactions were effected pursuant to a Rule 10b5-1 plan.
- Option became exercisable in four equal annual installments, commencing 4/2/2013.
- Option became exercisable in four equal annual installments, commencing 4/1/2014.
- Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, as such time as has been elected by the reporting person.
- Option became exercisable in four equal annual installments, commencing 4/1/2015.
- Option became exercisable in four equal annual installments, commencing 4/1/2016.
- Option became exercisable in four equal annual installments, commencing 4/1/2017.
- Option became exercisable in four equal annual installments, commencing 4/3/2018.
- Option becomes exercisable in four equal annual installments, commencing 4/1/2019.